A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea

Liver International

Volumn 29, Issue 2, 2009, Pages 147-152

  Seong, Jinsil ^a,k   Lee, Ik Jae ^a   Shim, Su Jung ^a   Lim, Do Hoon ^b   Kim, Tae Hyun ^c   Kim, Jong Hoon ^d   Jang, Hong Seok ^e   Kim, Mi Sook ^f   Chie, Eui Kyu ^g   Kim, Jin Hee ^h   Nam, Taek Keun ⁱ   Lee, Hyung Sik ^j   Han, Chul Joo ^f,k  

^a Yonsei University College of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c National Cancer Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

^f Korea Cancer Center Hospital   (South Korea)

^g Seoul National University College of Medicine   (South Korea)

^h Keimyung University   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Dong A University College of Medicine   (South Korea)

^k Korean Liver Cancer Study Association   (South Korea)

more..

Author keywords

Hepatocelluar carcinoma; Practice pattern; Radiotherapy

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; HOLMIUM;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PROGNOSIS; RADIATION DOSE; RADIOFREQUENCY ABLATION; RADIOSURGERY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; HUMANS; KOREA; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 58149528344     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01873.x     Document Type: Article

References (27)

1. Kim IH, Chie EK, Oh DH. A web-based 'Patterns of Care Study'system for clinical radiation oncology in Korea: Development, launching, and characteristics. J Korean Soc Ther Radiol Oncol 2003; 291-8.
2. Kim JH, Oh DH, Kang MK. Postoperative radiotherapy in the rectal cancers patterns of care study for the years of 1998-1999. Korean Soc Ther Radiol Oncol 2005; 23: 22-31.
3. Hur WJ, Choi Y, Lee HS, et al. Preliminary report of the 1998-1999 patterns of care study of radiation therapy for esophageal cancer in Korea. Korean Soc Ther Radiol Oncol 2007; 25: 79-92.
4. Keum KC, Shim SJ, Lee IJ, et al. The 1998, 1999 patterns of care study for breast irradiation after mastectomy in Korea. J Korean Soc Ther Radiol Oncol 2007; 25: 7-15.
5. Registry HoKCC. Annual Report on the Korea Central Cancer Registry Program, Annual Report on the Cause of Death Statistics, Ministry of Health and Welfare, 2005.
6. Joo KR, Bang SJ, Song BC, et al. Hepatitis B viral markers of Korean adults in the late 1990s: Survey data of 70347 health screenees. Korean J Gastroenterol 1999; 33: 642-52.
7. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-16.
8. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the study of the liver. J Hepatol 2001; 35: 421-30.
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
10. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial. Lancet 2002; 359: 1734-9.
11. Yuen MF, Chan AO, Wong BC, et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: Results of a comparative study in 96 Chinese patients. Am J Gastroenterol 2003; 98: 1181-5.
12. Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1999; 43: 393-7.
13. Seong J, Park HC, Han KH, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 2000; 47: 1331-5.
14. Seong J, Park HC, Han KH, et al. Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. Hepatol Res 2003; 27: 30-5.
15. Seong J, Park HC, Han KH, et al. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 2003; 55: 329-36.
16. Park W, Lim do H, Paik SW, et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2005; 61: 1143-50.
17. Kim DY, Park W, Lim DH, et al. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer 2005; 103: 2419-26.
18. Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 435-42.
19. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210-8.
20. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106: 720-7.
21. Okuda K, Tanaka M, Shibata J, et al. Hepatic arterial infusion chemotherapy with continuous low dose administration of cisplatin and 5-fluorouracil for multiple recurrence of hepatocellular carcinoma after surgical treatment. Oncol Rep 1999; 6: 587-91.
22. Chia-Hsien Cheng J, Chuang VP, Cheng SH, et al. Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization. Int J Cancer 2001; 96: 243-52.
23. Yoshikawa M, Ebara M, Ohto M, et al. A combination treatment of transcatheter arterial embolization (TAE) and irradiation for hepatocellular carcinoma (HCC) - evaluation for therapeutic efficacy in comparison with TAE or irradiation alone. Nippon Shokakibyo Gakkai Zasshi 1990; 87: 225-34.
24. Shim SJ, Seong J, Han KH, et al. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma. Liver Int 2005; 25: 1189-96.
25. Seong J, Shim SJ, Lee IJ, et al. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67: 1037-42.
26. Yeo W, Mok TS, Zee B, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 2005; 97: 1532-8.
27. Llovet J, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-90.